Update on US FDA Application for Artrya Salix

Change of Director’s Interest Notice – John Barrington

Application for quotation of securities – AYA

Quarterly Activity Report and Appendix 4C for Q3 FY22

Application for quotation of securities – AYA

Quarterly Conference Call Details

Artrya Signs First U.S. Hospital Clinical Partnership

Release of Shares from Escrow

Change of Director’s Interest Notice – Bernie Ridgeway

Notification regarding unquoted securities – AYA